VACCIBODY

Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company founded in 2006. Our bold aim is to generate game-changing therapeutics to treat cancers and infectious diseases with a high unmet medical need... Our core Values form a deep and robust foundation for our positions, principles, and policies. They inspire us every day and guide everything we do... The Nykode Therapeutics platform is built around the Vaccibody molecule: A vaccine platform for the future of medicine.

Also known as: Vaccibody AS

Registration numbers: 990 646 066 (W)

Primary location: Oslo Norway